SCHEMBL7499252

SCHEMBL7499252

N#CC(=O)Oc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
HSD17B10 Q99714 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALOX15 P16050 2/20 0.44
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NSD2 O96028 1/20 0.41
ELANE P08246 1/20 0.39
AKR1C3 P42330 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP19A1 P11511 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10923518 0.83 KMT2A (0.53) L3MBTL1CYP3A4MAPTKDM4EALDH1A1
SCHEMBL4544920 0.81 TDP1 (0.48) ATMTDP1L3MBTL1HSD17B10RAB9A
SCHEMBL735728 0.79 TDP1 (0.47) ATMTDP1L3MBTL1HSD17B10RAB9A
SCHEMBL10962554 0.78 KMT2A (0.56) TDP1L3MBTL1HSD17B10NPC1CYP1A2
SCHEMBL10411906 0.77 TDP1 (0.45) ATMTDP1L3MBTL1HSD17B10RAB9A
SCHEMBL505224 0.77 THRA (0.49) ATMTDP1L3MBTL1HSD17B10RAB9A
SCHEMBL5954678 0.76 HSD17B10 (0.40) ATMTDP1L3MBTL1HSD17B10NPC1
SCHEMBL29211141 0.76 TDP1 (0.44) ATMTDP1L3MBTL1HSD17B10RAB9A
SCHEMBL9190844 0.76 THRA (0.47) ATMTDP1L3MBTL1HSD17B10RAB9A
SCHEMBL27737478 0.76 THRA (0.47) ATMTDP1L3MBTL1HSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114516824-A Thioamide carboxylic ester and synthetic method thereof 广州佳途科技股份有限公司 2022-05-20 CN claimed
CN-110372582-A A kind of synthesis technology of betrixaban 江苏恒盛药业有限公司 2019-10-25 CN claimed
CN-114516824-A Thioamide carboxylic ester and synthetic method thereof 广州佳途科技股份有限公司 2022-05-20 CN disclosed
EP-0911335-B1 Method for producing furopyridine derivatives and intermediate compounds KURARAY CO (JP) 2002-04-17 EP disclosed
EP-0893436-B1 Process for producing cyanoformate esters CREANOVA INC (US) 2002-03-27 EP disclosed
US-6342606-B2 REACTING PYRIDINE ESTER DERIVATIVE WITH A REDUCING AGENT, AN ALKYLATING AGENT, AN ALKENYLATING AGENT, AN ARYLATING AGENT OR AN ARALKYLATING AGENT TO OBTAIN A PYRIDINE CARBONYL DERIVATIVE, REDUCING KURARAY CO., LTD. (JP) 2002-01-29 US disclosed
US-20010031871-A1 Method for producing pyridine derivatives KURARAY CO., LTD. (JP) 2001-10-18 US disclosed
US-6265580-B1 REACTING AMINE DERIVATIVE WITH CARBONYLATING AGENT AND NITRILE DERIVATIVE KURARAY CO., LTD. (JP) 2001-07-24 US disclosed
US-6111111-A Intermediates for producing pyridine derivatives KURARAY CO., LTD. (JP) 2000-08-29 US disclosed
EP-0911335-A2 Method for producing furopyridine derivatives and intermediate compounds KURARAY CO., LTD. (JP) 1999-04-28 EP disclosed
EP-0893436-A1 Process for producing cyanoformate esters Creanova Inc. (US) 1999-01-27 EP disclosed
US-5852207-A Process for producing cyanoformate esters CREANOVA INC. (US) 1998-12-22 US disclosed
US-3986973-A CYANOFORMATES AND CYANOFORMAMIDES AS BLEACH ACTIVATORS AMERICAN CYANAMID COMPANY (US) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031871-A1 Method for producing pyridine derivatives CYP2E1, CBR1, CBR3 ATM 2644/4885TDP1 3188/4885L3MBTL1 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.